Neumora Therapeutics, Inc. Common Stock
NMRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57 | -$53 | -$68 | -$59 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $7 | $9 | $10 |
| Change in WC | $4 | -$8 | -$1 | -$1 |
| Other Non-Cash | -$0 | $1 | -$0 | -$0 |
| Operating Cash Flow | -$47 | -$52 | -$59 | -$50 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$39 | -$44 | -$107 |
| Inv. Sales/Matur. | $51 | $69 | $89 | $8 |
| Other Inv. Act. | $0 | $1 | $0 | $0 |
| Investing Cash Flow | $51 | $30 | $44 | -$99 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $18 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $14 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $2 |
| Financing Cash Flow | -$0 | $18 | $0 | $16 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5 | -$4 | -$15 | -$134 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $125 | $128 | $143 | $277 |
| End Cash | $129 | $125 | $128 | $143 |
| Free Cash Flow | -$47 | -$52 | -$59 | -$50 |